IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q4 2019 Holdings

Filed 2020-02-05 | 4 holdings | $226.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Fulcrum Therapeutics, Inc.(FULC)COM359616109$99.2K5,962,20243.8%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$89.2K6,391,17639.4%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$26.6K3,048,78011.8%
Neon Therapeutics, Inc.COM64050Y100$11.5K9,741,6365.1%